PAVmed (PAVM) Cash & Equivalents (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -51.66% |
| Sep 30, 2025 | -22.50% |
| Jun 30, 2025 | 48.30% |
| Mar 31, 2025 | 127.85% |
| Jun 30, 2024 | -0.14% |
| Mar 31, 2024 | 30.03% |
| Dec 31, 2023 | -25.63% |
| Sep 30, 2023 | -28.94% |
| Jun 30, 2023 | -24.59% |
| Mar 31, 2023 | 23.99% |
| Dec 31, 2022 | -30.01% |
| Sep 30, 2022 | -12.84% |
| Jun 30, 2022 | 0.64% |
| Mar 31, 2022 | -16.21% |
| Dec 31, 2021 | 106.90% |
| Sep 30, 2021 | -13.58% |
| Jun 30, 2021 | -10.99% |
| Mar 31, 2021 | 181.33% |
| Dec 31, 2020 | 108.08% |
| Sep 30, 2020 | 17.13% |
| Jun 30, 2020 | -18.91% |
| Mar 31, 2020 | 40.39% |
| Dec 31, 2019 | 51.77% |
| Sep 30, 2019 | -40.69% |
| Jun 30, 2019 | 64.85% |
| Mar 31, 2019 | -49.03% |
| Dec 31, 2018 | -11.03% |
| Sep 30, 2018 | -17.02% |
| Jun 30, 2018 | 206.76% |
| Mar 31, 2018 | 136.52% |
| Dec 31, 2017 | -50.67% |
| Sep 30, 2017 | 3,692.05% |
| Jun 30, 2017 | -90.94% |
| Mar 31, 2017 | 54.63% |
| Dec 31, 2016 | -67.26% |
| Sep 30, 2016 | -40.83% |
| Jun 30, 2016 | 1,180.58% |
| Mar 31, 2016 | -69.23% |
| Dec 31, 2015 | -45.79% |
| Sep 30, 2015 | 171.35% |